Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Jacques Kiladjian

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Haematologica|December 17, 2013
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety studyLuigi Gugliotta, Carlos Besses, Martin Griesshammer, et al.
Blood|October 9, 2012
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysisJasper H Smalberg, Lidia R Arends, Dominique C Valla, et al.
Haematologica|October 29, 2017
Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety studyGunnar Birgegård, Carlos Besses, Martin Griesshammer, et al.
Nature Reviews. Disease Primers|April 17, 2025
Polycythaemia veraClaire N Harrison, Tiziano Barbui, Prithviraj Bose, et al.
Therapie|August 27, 2022
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infectionsZineb Ghrieb, Maud Salmona, David Michonneau, et al.
Blood|July 25, 2008
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraJean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, et al.
Therapie|February 6, 2024
[Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic]Zineb Ghrieb, Anouk Walter-Petrich, Jin Huang, et al.
Leukemia Research|February 15, 2017
Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapySrdan Verstovsek, Claire N Harrison, Jean-Jacques Kiladjian, et al.
Haematologica|February 13, 2008
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromesJean-Jacques Kiladjian, Géraldine Visentin, Emilie Viey, et al.
Haematologica|September 22, 2011
Neurological disorders in essential thrombocythemiaSegolene Billot, Eirini G Kouroupi, Johan Le Guilloux, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Haematologica|December 17, 2013
Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety studyLuigi Gugliotta, Carlos Besses, Martin Griesshammer, et al.
Blood|October 9, 2012
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysisJasper H Smalberg, Lidia R Arends, Dominique C Valla, et al.
Haematologica|October 29, 2017
Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safety studyGunnar Birgegård, Carlos Besses, Martin Griesshammer, et al.
Nature Reviews. Disease Primers|April 17, 2025
Polycythaemia veraClaire N Harrison, Tiziano Barbui, Prithviraj Bose, et al.
Therapie|August 27, 2022
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infectionsZineb Ghrieb, Maud Salmona, David Michonneau, et al.
Blood|July 25, 2008
Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia veraJean-Jacques Kiladjian, Bruno Cassinat, Sylvie Chevret, et al.
Therapie|February 6, 2024
[Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic]Zineb Ghrieb, Anouk Walter-Petrich, Jin Huang, et al.
Leukemia Research|February 15, 2017
Markers of iron deficiency in patients with polycythemia vera receiving ruxolitinib or best available therapySrdan Verstovsek, Claire N Harrison, Jean-Jacques Kiladjian, et al.
Haematologica|February 13, 2008
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromesJean-Jacques Kiladjian, Géraldine Visentin, Emilie Viey, et al.
Haematologica|September 22, 2011
Neurological disorders in essential thrombocythemiaSegolene Billot, Eirini G Kouroupi, Johan Le Guilloux, et al.
Pageof 21